What does TaiwanJ Pharmaceuticals Co., Ltd. do?

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6549.TWO's market cap?

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) has a market capitalization of approximately $564.1 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 6549.TWO pay a dividend?

No — TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 6549.TWO profitable?

TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6549.TWO

TaiwanJ Pharmaceuticals Co., Ltd.

TWO·Biotechnology · Healthcare

NT$7.04NT$0.00−0.00%

Market capNT$564.06M·Market closed·Aug 27 1:00 AM UTC

Price Chart

NT$7.04−NT$0.00 (−0.00%)today

−31.32%CAGR −7.24%

Select date range

FromTo

Oct 21, 2015Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

6549.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$0.00

Net Income−NT$18.35M

Net Margin—

Operating Cash Flow−NT$18.03M

Capital ExpendituresNT$0.00

Free Cash Flow−NT$18.03M

Return on Equity−28.5%

Return on Invested Capital−11.7%

Net CashNT$58.10M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6549.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6549.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6549.TWO and 80,000+ other tickers.

About TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's…

CEO: Hung-Chang Yuan
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 13
Website: www.taiwanj.com

Peers

Peers Tab

4170.TWO

Vectorite Biomedical Inc.

Cap

NT$555.9M

1781.TWO

Health & Life Co., Ltd.

Cap

NT$512.0M

6662.TWO

BioLASCO Taiwan Co., Ltd.

Cap

NT$755.6M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6549.TWO

What does TaiwanJ Pharmaceuticals Co., Ltd. do?: TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6549.TWO's market cap?: TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) has a market capitalization of approximately $564.1 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 6549.TWO pay a dividend?: No — TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 6549.TWO profitable?: TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.